Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenna Shaw

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
JAMA Network Open|March 6, 2020
Comparison of Real-Time Fluorescence Confocal Digital Microscopy With Hematoxylin-Eosin-Stained Sections of Core-Needle Biopsy SpecimensSavitri Krishnamurthy, Sharjeel Sabir, Kechen Ban, et al.
Oncotarget|February 29, 2020
Identification of biomarkers of immune checkpoint blockade efficacy in recurrent or refractory solid tumor malignanciesRichard K Yang, Yun Qing, Fatima Zahra Jelloul, et al.
JCO Precision Oncology|September 3, 2021
Retrospective Case Series Analysis of <i>RAF</i> Family Alterations in Pancreatic Cancer: Real-World Outcomes From Targeted and Standard TherapiesAndrew Hendifar, Edik M Blais, Brian Wolpin, et al.
Oncotarget|September 22, 2018
Prevalence of MDM2 amplification and coalterations in 523 advanced cancer patients in the MD Anderson phase 1 clinicVikas Dembla, Neeta Somaiah, Pedro Barata, et al.
JCO Precision Oncology|September 26, 2019
Active Disclosure of Secondary Germline Findings to Deceased Research Participants' Personal Representatives: Process and OutcomesMolly Daniels, Chetna Wathoo, Lauren Brusco, et al.
Oncotarget|April 22, 2017
Antiangiogenesis and gene aberration-related therapy may improve overall survival in patients with concurrent KRAS and TP53 hotspot mutant cancerZhijie Wang, Sarina Piha-Paul, Filip Janku, et al.
Oncotarget|July 16, 2016
MET amplification in metastatic colorectal cancer: an acquired response to EGFR inhibition, not a de novo phenomenonKanwal Raghav, Van Morris, Chad Tang, et al.
Cancer Research|November 3, 2017
"Personalized Cancer Therapy": A Publicly Available Precision Oncology ResourceKatherine C Kurnit, Ann M Bailey, Jia Zeng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2018
Distinct Biological Types of Ocular Adnexal Sebaceous Carcinoma: HPV-Driven and Virus-Negative Tumors Arise through Nonoverlapping Molecular-Genetic AlterationsMichael T Tetzlaff, Jonathan L Curry, Jing Ning, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2015
Feasibility of Large-Scale Genomic Testing to Facilitate Enrollment Onto Genomically Matched Clinical TrialsFunda Meric-Bernstam, Lauren Brusco, Kenna Shaw, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
JAMA Network Open|March 6, 2020
Comparison of Real-Time Fluorescence Confocal Digital Microscopy With Hematoxylin-Eosin-Stained Sections of Core-Needle Biopsy SpecimensSavitri Krishnamurthy, Sharjeel Sabir, Kechen Ban, et al.
Oncotarget|February 29, 2020
Identification of biomarkers of immune checkpoint blockade efficacy in recurrent or refractory solid tumor malignanciesRichard K Yang, Yun Qing, Fatima Zahra Jelloul, et al.
JCO Precision Oncology|September 3, 2021
Retrospective Case Series Analysis of <i>RAF</i> Family Alterations in Pancreatic Cancer: Real-World Outcomes From Targeted and Standard TherapiesAndrew Hendifar, Edik M Blais, Brian Wolpin, et al.
Oncotarget|September 22, 2018
Prevalence of MDM2 amplification and coalterations in 523 advanced cancer patients in the MD Anderson phase 1 clinicVikas Dembla, Neeta Somaiah, Pedro Barata, et al.
JCO Precision Oncology|September 26, 2019
Active Disclosure of Secondary Germline Findings to Deceased Research Participants' Personal Representatives: Process and OutcomesMolly Daniels, Chetna Wathoo, Lauren Brusco, et al.
Oncotarget|April 22, 2017
Antiangiogenesis and gene aberration-related therapy may improve overall survival in patients with concurrent KRAS and TP53 hotspot mutant cancerZhijie Wang, Sarina Piha-Paul, Filip Janku, et al.
Oncotarget|July 16, 2016
MET amplification in metastatic colorectal cancer: an acquired response to EGFR inhibition, not a de novo phenomenonKanwal Raghav, Van Morris, Chad Tang, et al.
Cancer Research|November 3, 2017
"Personalized Cancer Therapy": A Publicly Available Precision Oncology ResourceKatherine C Kurnit, Ann M Bailey, Jia Zeng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2018
Distinct Biological Types of Ocular Adnexal Sebaceous Carcinoma: HPV-Driven and Virus-Negative Tumors Arise through Nonoverlapping Molecular-Genetic AlterationsMichael T Tetzlaff, Jonathan L Curry, Jing Ning, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2015
Feasibility of Large-Scale Genomic Testing to Facilitate Enrollment Onto Genomically Matched Clinical TrialsFunda Meric-Bernstam, Lauren Brusco, Kenna Shaw, et al.
Pageof 3